| For: | He SD, Tian Y. Upadacitinib for ulcerative colitis and pyoderma gangrenosum in a patient with schizophrenia on long-term risperidone: A case report. World J Gastroenterol 2025; 31(20): 104038 [PMID: 40495949 DOI: 10.3748/wjg.v31.i20.104038] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v31/i20/104038.htm |
| Number | Citing Articles |
| 1 |
Gai Ge, Lirui Zhan, Meng Huang, Fei Su, Jinbo Chen, Jing Dong. Case Report: Treatment of facial pyoderma gangrenosum with Upadacitinib. Frontiers in Medicine 2025; 12 doi: 10.3389/fmed.2025.1665013
|
| 2 |
Seyed Mohammad Vahabi, Sama Heidari, Yalda Farahmand, Elnaz Pourgholi, Nika Kianfar, Huria Memari, Farzad Esmaeili, Saeed Bahramian, Ifa Etesami, Mahshid Sadat Ansari, Anjali Chauhan. JAK Inhibitors for Treatment of Pyoderma Gangrenosum and Sweet Syndrome: A Systematic Review of Published Case Reports. Dermatology Research and Practice 2026; 2026(1) doi: 10.1155/drp/7086209
|
| 3 |
|
| 4 |
Mark Gregory, Negar Esfandiari, Steven Daveluy. Upadacitinib for the treatment of pyoderma gangrenosum: A literature review. JAAD Reviews 2026; 8 doi: 10.1016/j.jdrv.2026.03.007
|